نتایج جستجو برای: 2 heart hypertrophy rat triiodothyronine treatment

تعداد نتایج: 4062190  

2017
Chen yunzhi Chen jiaxu Gao jie Chai yihui Li wen Qin zhong

BACKGROUND Astragaloside, which is one of the main components of Astragalus membranaceus, has been widely used in the treatment of congestive heart failure in China, and it can protect cardiomyocytes. Its mechanism of action remains unclear. Therefore, the present study was carried out to investigate the influence of astragaloside on rat cardiomyocytes stimulated with endothelin-1 (ET-1), and e...

Journal: :The Journal of clinical investigation 1999
G Choukroun R Hajjar S Fry F del Monte S Haq J L Guerrero M Picard A Rosenzweig T Force

Cardiac hypertrophy often presages the development of heart failure. Numerous cytosolic signaling pathways have been implicated in the hypertrophic response in cardiomyocytes in culture, but their roles in the hypertrophic response to physiologically relevant stimuli in vivo is unclear. We previously reported that adenovirus-mediated gene transfer of SEK-1(KR), a dominant inhibitory mutant of t...

Journal: :Hypertension 2016
Xiaoying Ying Yichao Zhao Tianbao Yao Ancai Yuan Longwei Xu Lingchen Gao Song Ding Hongyi Ding Jun Pu Ben He

Ubiquitin-specific protease 18 (USP18), a USP family member, is involved in antiviral activity and cancer inhibition. Although USP18 is expressed in heart, the role of USP18 in the heart and in cardiac diseases remains unknown. Here, we show that USP18 expression is elevated in both human dilated hearts and hypertrophic murine models. Cardiomyocyte-specific overexpression of USP18 in mice signi...

2013
Silvio Antoniak Erica M. Sparkenbaugh Michael Tencati Mauricio Rojas Nigel Mackman Rafal Pawlinski

Heart failure is a major clinical problem worldwide. Previous studies have demonstrated an important role for G protein-coupled receptors, including protease-activated receptors (PARs), in the pathology of heart hypertrophy and failure. Activation of PAR-2 on cardiomyocytes has been shown to induce hypertrophic growth in vitro. PAR-2 also contributes to myocardial infarction and heart remodelin...

Journal: :American journal of physiology. Heart and circulatory physiology 2014
Wenwen Ding Ming Dong Jianxin Deng Dewen Yan Yun Liu Teng Xu Jie Liu

Polydatin (PD), a resveratrol glucoside extracted from the perennial herbage Polygonum cuspidatum, has been suggested to have wide cardioprotective effects. This study aimed to explore the direct antihypertrophic role of PD in cultured neonatal rat ventricular myocytes (NRVMs) and its therapeutic effects against pressure overload (PO)-induced hypertrophic remodeling and heart failure. Furthermo...

2017
Shilpa Rani Pradeep Kumar Sreenivasaiah Chunghee Cho Do Han Kim

Pathological hypertrophy of the heart is closely associated with endoplasmic reticulum stress (ERS), leading to maladaptations such as myocardial fibrosis, induction of apoptosis, and cardiac dysfunctions. Salubrinal is a known selective inhibitor of protein phosphatase 1 (PP1) complex involving dephosphorylation of phospho-eukaryotic translation initiation factor 2 subunit (p-eIF2)-α, the key ...

2017
Tarak N. Khatua Roshan M. Borkar Soheb A. Mohammed Amit K. Dinda R. Srinivas Sanjay K. Banerjee

Epidemiologic studies show an inverse correlation between garlic consumption and progression of cardiovascular disease. However, the molecular basis for the beneficial effect of garlic on the heart is not known. Therefore, the objective of the present study was to (1) investigate the effect of raw garlic on isoproterenol (Iso) induced cardiac hypertrophy (2) find the active metabolites of garli...

Journal: :American journal of physiology. Heart and circulatory physiology 2007
Ye Chen-Izu Christopher W Ward Wayne Stark Tamas Banyasz Marius P Sumandea C William Balke Leighton T Izu Xander H T Wehrens

As a critical step toward understanding the role of abnormal intracellular Ca(2+) release via the ryanodine receptor (RyR(2)) during the development of hypertension-induced cardiac hypertrophy and heart failure, this study examines two questions: 1) At what stage, if ever, in the development of hypertrophy and heart failure is RyR(2) hyperphosphorylated at Ser(2808)? 2) Does the spatial distrib...

Journal: :Cardiology 2016
Guan-Sheng Liu

tan. Indeed, several selective AT1 antagonists have been shown to prevent or reverse the progression of cardiac dilatation and hypertrophy via multiple intracellular signaling pathways. Specifically, it has been discovered that candesartan, an AT1 antagonist, is able to suppress β-adrenergic receptor stimulation-induced cardiac hypertrophy and remodeling via the Raf (proto-oncogene serine/ thre...

Journal: :Diabetes 2002
Robert J Sidell Mark A Cole Nicholas J Draper Martine Desrois Robin E Buckingham Kieran Clarke

Obesity is associated with risk factors for cardiovascular disease, including insulin resistance, and can lead to cardiac hypertrophy and congestive heart failure. Here, we used the insulin-sensitizing agent rosiglitazone to investigate the cellular mechanisms linking insulin resistance in the obese Zucker rat heart with increased susceptibility to ischemic injury. Rats were treated for 7 or 14...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید